These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4267531)

  • 1. Continuous intravenous infusions of 5-fluoro-2'-deoxyuridine in the treatment of solid tumors.
    DeConti RC; Kaplan SR; Papac RJ; Calabresi P
    Cancer; 1973 Apr; 31(4):894-8. PubMed ID: 4267531
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled comparison of 5-fluoro-2'-deoxyuridine therapy administered by rapid intravenous injection and by continuous intravenous infusion.
    Moertel CG; Reitemeier RJ; Hahn RG
    Cancer Res; 1967 Mar; 27(3):549-52. PubMed ID: 4225560
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks.
    Hill GJ; Grage TB; Wilson W; Ansfield FJ
    J Surg Oncol; 1972; 4(1):60-70. PubMed ID: 5033956
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG).
    Jacobs EM; Reeves WJ; Wood DA; Pugh R; Braunwald J; Bateman JR
    Cancer; 1971 Jun; 27(6):1302-5. PubMed ID: 5088208
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination chemotherapy in gastrointestinal cancer.
    Reitemeier RJ; Moertel CG; Hahn RG
    Cancer Res; 1970 May; 30(5):1425-8. PubMed ID: 4246651
    [No Abstract]   [Full Text] [Related]  

  • 6. [Continuous intra-arterial infusion of 5-fluor-2-deoxyuridine in primary and metastatic liver cancer].
    Baden H
    Ugeskr Laeger; 1968 Apr; 130(17):721-7. PubMed ID: 4301598
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of fluorinated pyrimidines in advanced malignancy.
    Fennelly JJ; Fitzgerald MX
    Br J Cancer; 1968 Dec; 22(4):673-82. PubMed ID: 4236543
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of cancer with weekly intravenous 5-fluorouracil.
    Jacobs EM; Luce JK; Wood DA
    Cancer; 1968 Dec; 22(6):1233-8. PubMed ID: 5705785
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term, ambulatory, continuous IV infusion of 5-FU for the treatment of advanced adenocarcinomas.
    Caballero GA; Ausman RK; Quebbeman EJ
    Cancer Treat Rep; 1985 Jan; 69(1):13-5. PubMed ID: 3155649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infusion of floxuridine in the treatment of solid tumors.
    Papac RJ; Calabresi P
    JAMA; 1966 Jul; 197(4):237-41. PubMed ID: 4287261
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitomycin-C in the therapy of far-advanced malignant tumors.
    Manheimer LH; Vital J
    Cancer; 1966 Feb; 19(2):207-12. PubMed ID: 5905463
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent trends in chemotherapy of solid tumors.
    Oberfield RA
    Med Clin North Am; 1975 Mar; 59(2):399-409. PubMed ID: 163943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
    Van Dyk JJ; Clarkson BD; Duschinsky R; Keller O; La Sala E; Krakoff IH
    Cancer Res; 1967 Nov; 27(11):2129-36. PubMed ID: 4294532
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigational and practical chemotherapy of solid tumors.
    Talley RW
    Geriatrics; 1970 Oct; 25(10):113-25. PubMed ID: 5528232
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.
    Ensminger WD; Rosowsky A; Raso V; Levin DC; Glode M; Come S; Steele G; Frei E
    Cancer Res; 1978 Nov; 38(11 Pt 1):3784-92. PubMed ID: 151583
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phase II study of 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with malignant cancer--a multi-institutional cooperative study].
    Niitani H; Kimura K; Saito T; Nakao I; Abe O; Urushizaki I; Ohta K; Yoshida Y; Kimura T; Kurihara M
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2044-51. PubMed ID: 2932059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic infusion of 5-fluoro-2'-deoxyuridine (5-FUDR) into the hepatic artery of the dog.
    Khazei AM; Patel DD; Morgenthaler FR; MacDonald AJ; Sanadizadeh SM; Watkins E
    J Surg Res; 1970 Aug; 10(8):343-52. PubMed ID: 4193563
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of 5-fluorouracil (NSC-19893) in 389 patients with cancer. Eastern Clinical Drug Evaluation Program.
    Moore GE; Bross ID; Ausmans R; Nadler S; Jones R; Slack N; Rimm AA
    Cancer Chemother Rep; 1968 Oct; 52(6):641-53. PubMed ID: 4895427
    [No Abstract]   [Full Text] [Related]  

  • 19. FURTHER CLINICAL COMPARISON BETWEEN 5-FLUOROURACIL (5-FU) AND 5-FLUORO-2' -DEOXYURIDINE (5-FUDR).
    ANSFIELD FJ; CURRERI AR
    Cancer Chemother Rep; 1963 Oct; 32():101-5. PubMed ID: 14088828
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I study of continuous venous infusion of floxuridine (5-FUDR) chemotherapy.
    Lokich JJ; Sonneborn H; Paul S; Zipoli T
    Cancer Treat Rep; 1983 Sep; 67(9):791-3. PubMed ID: 6224555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.